Skip to the beginning of the images gallery

CNS Company

James E. Hatch ; Chris K. Anderson ; Soren Milo Christensen ; Christen Hagelund

Reference: IVEY-9B04N004-E
Year: 2002
Number of pages: 12
Geographic Setting: Denmark
Publication Date: Mar 4, 2004
Fecha de edición: Aug 8, 2005
Source: Ivey Business School (Canada)
Type of Document: Case
Industry Setting: Manufacturing;

Grouped product items
Format	Language	Reference	Use	Qty	Price	Preview
pdf	English	IVEY-9B04N004-E			As low as €6.75	Preview

You already have a subscription

To order please contact the person in charge of academic purchases in your university.

You'll be able to order once your profile has been validated.

Description

CNS is a small biotech company. The founder of the company is deciding if it's worth applying for phase I approval that will allow the company to continue its research. He must determine the value of the research. Using the traditional DCF valuation method, he is not sure if this captures all of the value of the research and must decide if either the Black-Scholes or binomial model would more accurately determine the value.

Keywords

data analysis Real options Valuation